Tamoxifen: a new risk factor for cerebral sinus thrombosis

Neurology. 2004 Jan 27;62(2):334-5. doi: 10.1212/01.wnl.0000103294.81923.12.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Anticoagulants / therapeutic use
  • Antineoplastic Agents, Hormonal / adverse effects*
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / radiotherapy
  • Breast Neoplasms / surgery
  • Confusion / etiology
  • Estrogen Receptor Modulators / adverse effects*
  • Estrogen Receptor Modulators / therapeutic use
  • Female
  • Heparin / therapeutic use
  • Humans
  • Mastectomy
  • Middle Aged
  • Risk Factors
  • Sinus Thrombosis, Intracranial / chemically induced*
  • Sinus Thrombosis, Intracranial / complications
  • Sinus Thrombosis, Intracranial / drug therapy
  • Tamoxifen / adverse effects*
  • Tamoxifen / therapeutic use

Substances

  • Anticoagulants
  • Antineoplastic Agents, Hormonal
  • Estrogen Receptor Modulators
  • Tamoxifen
  • Heparin